Biochips enable the accurate, rapid, and high-throughput detection of DNA, RNA, polypeptides, proteins, cells, tissues, and other biological components, with great advantages in disease screening and early diagnosis.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Biocept said recentlythat it has entered into a securities purchase agreement with certain accreditedinstitutional investors to purchase approximately 990,000 shares of its common stock at a price of $2.25 per share, resulting in gross proce

Through a newly announced partnership with Fabric Genomics, genetic testing company Diagnomics has developed an ACMG-59 report to help healthcare provider organizations understand pathogenic and likely pathogenic variants. The ACMG-59 is a

Recently, 10X Genomics announced a new round of funding during JPM. The fiancing ofD roundraised35million dollars,led by Meritech Capital and backed by Fidelity, Wells Fargo, Paladin Capital and softbank. 10X Genomics is a leader in the gene

A new enzyme biomarker test, developed by Researchers at the Institute for Global Food Security at Queens University Belfast, has the potential to indicate diseases and bacterial contamination. The nanosensor test can detect enzyme markers o

When our kidneys fail to function as they should, our treatment options generally begin with dialysis and end with a kidney transplant. Unfortunately, transplanted kidneys last, on average, between 12 years and 15 years (depending on if the

Recently, Sansure Biotech and Thermo Fisher Scientific (hereinafter referred to as: Thermo Fisher) signed a strategic cooperation agreement.The two sides will work together with their respective superior technologies and resources to carry

GenMark Diagnostics announced recently it has received 510(k) clearance from the US Food and Drug Administration for a molecular diagnostic panel assay to detect fungal pathogens from blood cultures of patients with suspected blood stream i

Recently AmoyDx ROS1 gene fusion detection kit (fluorescence PCR method) was approved by Taiwan Food and Drug Administration（TFDA). Prior to this, the AmoyDx ROS1 Gene Fusion Detection Kit has been approved by China NMPA, Japan PMDA and Ko

Foundation Medicine announced recently that its FoundationOne CDx genomic profiling assay has received regulatory approval from Japans Ministry of Health, Labour and Welfare (MHLW). The next-generation sequencing-based assay which was appro

Cepheid announced recently it has received CE-IVD clearance for a rapid molecular assay to measure viral load of hepatitis B in infected patients. The Xpert HBV Viral Load test measures HBV DNA levels in plasma or serum using the firms Gene